Literature DB >> 879271

Tubulointerstitial nephritis and glomerulonephritis in Brown-Norway rats immunized with heterologous glomerular basement membrane.

J L Robertson, G S Hill, D T Rowlands.   

Abstract

Tubulointerstitial nephritis and glomerulonephritis were produced in Brown-Norway rats (BN) by a single immunization with 2 mg of lyophilized bovine glomerular basement membrane. Tubulointerstitial nephritis was evident before glomerulonephritis. Antibody first bound to tubular basement membranes (TBM), and then the renal cortex was infiltrated with inflammatory cells. The TBM was split, and many renal tubules, especially proximal tubules, were destroyed. Approximately 14 days after the beginning of the tubular phase, antibody was observed to be bound to glomerular basement membranes (GBM) in linear fashion. There was epithelial and mesangial cell proliferation, splitting and reduplication of GBM, crescent formation, and glomerular scarring and atrophy.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 879271      PMCID: PMC2032155     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  10 in total

1.  Specificity of autoantibodies to tubular and glomerular basement membranes induced in guinea pigs.

Authors:  D H Lehman; H Marquardt; D B Wilson; F J Dixon
Journal:  J Immunol       Date:  1974-01       Impact factor: 5.422

2.  Immunopathologic study of an autoimmune tubular and interstitial renal disease in brown Norway rats.

Authors:  T Sugisaki; J Klassen; F Milgrom; G A Andres; R T McCluskey
Journal:  Lab Invest       Date:  1973-06       Impact factor: 5.662

3.  Interstitial nephritis in rats immunized with heterologous tubular basement membrane.

Authors:  D H Lehman; C B Wilson; F J Dixon
Journal:  Kidney Int       Date:  1974-03       Impact factor: 10.612

4.  Antitubular basement membrane antibodies in rapidly progressive poststreptococcal glomerulonephritis: report of a case.

Authors:  L Morel-Maroger; O Kourilsky; F Mignon; G Richet
Journal:  Clin Immunol Immunopathol       Date:  1974-01

5.  Immunologic studies concerning the pulmonary lesions in Goodpasture's syndrome.

Authors:  D Koffler; J Sandson; R Carr; H G Kunkel
Journal:  Am J Pathol       Date:  1969-02       Impact factor: 4.307

6.  Chemical structure of tubular and glomerular basement membranes of human kidney. Isolation, purification, carbohydrate and amino acid composition.

Authors:  P Mahieu; R J Winand
Journal:  Eur J Biochem       Date:  1970-02

7.  Tubular lesions produced by autoantibodies to tubular basement membrane in human renal allografts.

Authors:  J Klassen; K Kano; F Milgrom; A B Menno; S Anthone; R Anthone; M Sepulveda; C M Elwood; G A Andres
Journal:  Int Arch Allergy Appl Immunol       Date:  1973

8.  Epithelial basement membrane of bovine renal tubuli. Isolation and chemical characterization.

Authors:  W Ferwerda; J F Meijer; D H van den Eijnden; W van Dijk
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1974-08

Review 9.  Chemical properties of basement membranes.

Authors:  N A Kefalides
Journal:  Int Rev Exp Pathol       Date:  1971

10.  Studies on the renal glomerular basement membrane. Preparation and chemical composition.

Authors:  R G Spiro
Journal:  J Biol Chem       Date:  1967-04-25       Impact factor: 5.157

  10 in total
  3 in total

Review 1.  Immunologically mediated lesions of kidney tubules and interstitium in laboratory animals and in man.

Authors:  J R Brentjens; B Noble; G A Andres
Journal:  Springer Semin Immunopathol       Date:  1982

2.  Experimental autoimmune tubulointerstitial nephritis in guinea-pigs: effects on renal lesions of cyclophosphamide administered before and after tubular basement membrane immunization on renal lesions.

Authors:  H Idikio
Journal:  Immunology       Date:  1982-08       Impact factor: 7.397

3.  Induction of autoimmunity to antigens of the glomerular basement membrane in inbred Brown-Norway rats.

Authors:  M Stuffers-Heiman; E Günther; L A van Es
Journal:  Immunology       Date:  1979-04       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.